This company has been marked as potentially delisted and may not be actively trading. NASDAQ:AMDA Amedica (AMDA) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisCompetitorsTrendsBuy This Stock About Amedica Stock (NASDAQ:AMDA) 30 days 90 days 365 days Advanced Chart Get Amedica alerts:Sign Up Key Stats Today's Range$2.67▼$3.0850-Day Range$0.09▼$2.1952-Week Range$0.18▼$6.40Volume61,600 shsAverage Volume1.07 million shsMarket Capitalization$31.93 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewSINTX Technologies, Inc. engages in the development and commercialization of silicon nitride for medical and non-medical applications. It markets spinal fusion products and develops products for use in total hip and knee joint replacements. The company was founded by Aaron A. Hofmann and Ashok C. Khandkar in 1996 and is headquartered in Salt Lake City, UT.Read More… Receive AMDA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Amedica and its competitors with MarketBeat's FREE daily newsletter. Email Address AMDA Stock News HeadlinesSINTX Technologies (SINT)September 13, 2024 | es.investing.comHere's the Best Way for Investors to Play the IPO MarketNovember 5, 2023 | thestreet.comThe Man I Turn to In Times Like ThisA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when publisher Brett Aitken turns to Whitney Tilson—a man CNBC once dubbed “The Prophet.” Tilson just released a new prediction that runs counter to what mainstream finance is telling you.May 2, 2025 | Stansberry Research (Ad)Silicon nitride ceramics Market 2022 | reach USD 683.74 million by 2028 - GlobeNewswireOctober 7, 2022 | globenewswire.comGlobal Interlaminar Device Market to Witness Growth by a CAGR of ~5% throughout 2022 – 2031 Owing to the - BenzingaMarch 27, 2022 | benzinga.comGlobal 3D Printed Medical Devices Market Report 2021: Market is Projected to Grow from $1.7 Billion in 20 - BenzingaFebruary 9, 2022 | benzinga.comGlobal 3D Printed Medical Devices Market Report 2021: Market is Projected to Grow from $1.7 Billion in 2021 to $4.9 Billion by 2026 - GlobeNewswireFebruary 9, 2022 | globenewswire.comSINTX TECHNOLOGIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q) - marketscreener.comNovember 12, 2021 | marketscreener.comSee More Headlines AMDA Stock Analysis - Frequently Asked Questions How were Amedica's earnings last quarter? Amedica Co. (NASDAQ:AMDA) posted its quarterly earnings data on Tuesday, November, 21st. The medical equipment provider reported ($0.93) earnings per share for the quarter, topping analysts' consensus estimates of ($0.94) by $0.01. The medical equipment provider had revenue of $2.96 million for the quarter. Amedica had a negative net margin of 139.62% and a negative trailing twelve-month return on equity of 148.60%. When did Amedica's stock split? Amedica's stock reverse split on Friday, November 10th 2017. The 1-12 reverse split was announced on Friday, November 10th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, November 9th 2017. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split. What other stocks do shareholders of Amedica own? Based on aggregate information from My MarketBeat watchlists, some other companies that Amedica investors own include Intrepid Potash (IPI), ParkerVision (PRKR), Net Element (NETE), Pernix Therapeutics (PTX), Synergy Pharmaceuticals (SGYP), Anavex Life Sciences (AVXL) and GE Aerospace (GE). Company Calendar Last Earnings11/21/2017Today5/02/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & Medical Instruments Sub-IndustryN/A Current SymbolNASDAQ:AMDA CIK1269026 Webwww.amedica.com Phone(855) 839-3500FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)($3.13) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-9,320,000.00 Net Margins-139.62% Pretax MarginN/A Return on Equity-148.60% Return on Assets-67.83% Debt Debt-to-Equity RatioN/A Current Ratio1.11 Quick Ratio0.99 Sales & Book Value Annual Sales$11.23 million Price / Sales2.84 Cash FlowN/A Price / Cash FlowN/A Book Value$1.80 per share Price / Book1.49Miscellaneous Outstanding Shares11,870,000Free FloatN/AMarket Cap$31.93 million OptionableNot Optionable Beta-1.24 5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (NASDAQ:AMDA) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amedica Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.